This boost comes at a critical time when India’s healthcare sector is grappling with post-pandemic challenges, an increasing burden of non-communicable diseases, and the urgent need for robust ...
Leading global drugmakers such as MSD Pharmaceuticals, Novartis, AstraZeneca, and Pfizer stand to benefit as it opens new opportunities to expand access to their medicines through PAPs.